Plecanatide vs Trefoil factor 2
Head-to-head comparison of Plecanatide (Plecanatide) and Trefoil factor 2 (Trefoil factor 2 (Spasmolytic Polypeptide)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Plecanatide | Trefoil factor 2 |
|---|---|---|
| Category | Gastrointestinal | Gastrointestinal |
| Full Name | Plecanatide | Trefoil factor 2 (Spasmolytic Polypeptide) |
| Molecular Weight | Approx. 1620 Da | ≈11–12 kDa |
| Half-Life | Local intestinal action; systemic half-life not clinically meaningful | Unknown |
| Amino Acids | 16 | 106 |
| Typical Dose | 3 mg once daily | none established |
| Route | Oral | oral/enteral|research-only |
| Purity | ≥98% | ≥98% |
| Studies Count | 350 | 80 |
| Research Status | Clinical | Pre-clinical |
Plecanatide Benefits
- ✓improves-stool-frequency
- ✓supports-fluid-secretion
- ✓may-reduce-constipation
- ✓local-gut-action
Trefoil factor 2 Benefits
- ✓epithelial restitution
- ✓barrier protection
- ✓ulcer healing
Plecanatide Dosing
3 mg PO daily|take with or without food|avoid when dehydrated
Trefoil factor 2 Dosing
No established clinical dose|preclinical only
Plecanatide Side Effects
- ⚠diarrhea
- ⚠abdominal-discomfort
- ⚠nausea
Trefoil factor 2 Side Effects
- ⚠limited human data
- ⚠theoretical growth-factor concerns
- ⚠GI discomfort
Research Overview
Plecanatide
Clinical trials show plecanatide improves constipation outcomes with a generally favorable tolerability profile. Like linaclotide, it acts locally in the intestinal lumen via GC-C signaling rather than systemic hormone effects.
Trefoil factor 2
TFF2 strengthens mucus-barrier repair and epithelial restitution after gastric injury in experimental systems, making it a well-known gastric-protective peptide.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.